Market Synopsis of the Global Biological computers Market
Biological computers are systems developed form basic components such as software, hardware, input and output. DNA and RNA are the basis of biological systems used as software for constructing the biological systems.
Prevalence of cancer such as lung cancer, mouth cancer, and bone cancer is on the rise across the globe, especially in the developing countries. The market is driven by the increasing prevalence of respiratory diseases in rural areas for developing countries. In addition, increasing research and development activities in the field of oncology, and technological advancements made to identify the causes and risk factors for chronic diseases have added fuel to the global biological computers market growth. Rising awareness about gene chip and other biological systems that can be used for cell transformation with the help of information technology also drives the market growth.
Biological computers, also known as DNA computers, are microcomputers designed for their use in the field of medicine. This implantable device can be used for various functions such as monitoring the activities of the body or inducing therapeutic effects. Hardware, software, input, and output are the four major components of a biological computer. These components are made of DNA, RNA and proteins. Biological computers are able to perform mathematical calculations that enable the researcher to construct a system of biosensors. This system of biosensors can detect or target specific types of cells such as cancer cells in the patient’s body.
As per the report of the Centers for Disease Control and Prevention (CDC), in 2014, over 14.1 million of new cancer cases were registered worldwide.
The global biological computers market is expected to grow at a CAGR of 7.1% during the forecast period 2017-2023.
Key Players
- Microsoft (U.S.)
- IBM (U.S.)
- Thermofisher Scientific (U.S.)
- Illumina, Inc. (U.S.)
- IndieBio (U.S.)
- Emulate Inc. (U.S.)
Key Players manufactruing DNA or gene chips
- Sequenom Inc.
- Merck KGaA (U.S.)
- Macrogen Corp (Republic of Korea)
- Bioneer Corporation (Republic of Korea)
- Biometrix Technology Inc (U.S.)
- Wafergen Biosystems Inc. (U.S.)
- Eurofins Genomics India Pvt Ltd. (India)
Segmentation
The global biological computers market is segmented on the basis of component, application, and end user.
On the basis of the component, market is segmented into hardware, software, input, and output.
On the basis of the application, the market is segmented into oncology, molecular genetics, nanobiotechnology, and others.
On the basis of the end user, the market is segmented into pharmaceutical & biotechnology companies, research centers, healthcare it companies, hospital & clinics, and others.
Regional Analysis
The Americas hold the first position in the biological computers market owing to the rising prevalence of cancer in the U.S., and increasing demand for new cancer diagnostic and treatment services. In the Americas, North America is the largest market owing to the presence of key players in the healthcare IT industry.
Europe is the second largest market for biological computers. In Europe, there is an increasing demand for healthcare IT solutions and extensive research and development activities is taking place by clinical research and academic institutes for cancer treatment. According to Cancer Research UK, in 2014, 356,860 new cases of cancer were reported, including 579 cases of bone cancer.
The market in Asia Pacific is expected to grow at the fastest pace and is driven by the high prevalence of chronic disease such as cancer, obesity, diabetes and other. India, China, and Japan are major contributors to the growth of the market. This growth is attributed to an increasing demand for technologically advanced medical devices and accessories such as gene chips for research activities. Availability of highly qualified medical professionals dedicated to research in biological systems is also a contributing factor. The various other factors affecting the growth of the market in Asia Pacific are rising geriatric population, demand for advanced therapies, government initiatives, and increasing public awareness about various diseases and the available treatments.
Additionally, healthcare spending in Asia Pacific expanded in 2016 due to an extension of state healthcare programs, and the increasing affluence of the population. Organization for Economic Co-operation and Development (ECOD) stated that growth in India will remain high at 7.3% in 2017.
The Middle East & Africa also show a steady rise in the market owing to low technological penetration and increasing awareness about cancer treatment. In the Middle East & Africa, Middle East captures the largest market share for biological medicines owing to the availability of better healthcare infrastructure and wide scope for research.
Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/biological-computers-market-5067
No comments:
Post a Comment